TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
6.1Bids / Report
35% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 182 active published awards; 180 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published3 Apr 2024, 11:53 BST
Last source update3 Apr 2024, 11:53 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-040faf
What is being bought
Proposed NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)<br/>Tender Reference: CM/PHR/22/5686/01<br/> <br/>Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
What changed
From the official release history
  1. tender value changed
    3 Apr 2024, 11:53 BST
  2. Status changed to complete
    3 Apr 2024, 11:53 BST
  3. Official notice release published
    3 Apr 2024, 11:53 BST
  4. Submission deadline changed to published date
    3 Apr 2024, 11:53 BST
  5. Buyer information updated
    3 Apr 2024, 11:53 BST
  6. Published value updated to £624,000,000
    27 Oct 2023, 13:48 BST
  7. Status changed to active
    27 Oct 2023, 13:48 BST
  8. Official notice release published
    27 Oct 2023, 13:48 BST
  9. Submission deadline changed to 1 Dec 2023, 13:00 GMT
    27 Oct 2023, 13:48 BST
  10. Buyer information updated
    27 Oct 2023, 13:48 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) 1 April 2024 to 31 March 2028 -East, SouthEast, London, NOFE
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    3 Apr 2024, 11:53 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Contract active
    Signed 11 Mar 2024, 00:00 GMT · £1
  9. Contract active
    Signed 11 Mar 2024, 00:00 GMT · £1
  10. Contract active
    Signed 11 Mar 2024, 00:00 GMT · £1
  11. Contract active
    Signed 11 Mar 2024, 00:00 GMT · £1
  12. Contract active
    Signed 11 Mar 2024, 00:00 GMT · £1
  13. Contract active
    Signed 11 Mar 2024, 00:00 GMT · £1
Commercial outcome and competition
Awards
Quantum Pharmaceutical
Not published · Not published · active
LloydsPharmacy Clinical Homecare
Not published · Not published · active
Baxter Healthcare Ltd
Not published · Not published · active
Sciensus Pharma Services Limited
Not published · Not published · active
Qualasept Ltd t/a Bath ASU
Not published · Not published · active
ITH Pharma
Not published · Not published · active
Contracts
Contract
£1 · signed 11 Mar 2024, 00:00 GMT · active
Contract
£1 · signed 11 Mar 2024, 00:00 GMT · active
Contract
£1 · signed 11 Mar 2024, 00:00 GMT · active
Contract
£1 · signed 11 Mar 2024, 00:00 GMT · active
Contract
£1 · signed 11 Mar 2024, 00:00 GMT · active
Contract
£1 · signed 11 Mar 2024, 00:00 GMT · active
Bid statistics
bids: 6 (lot 1)
bids: 6 (lot 1)
bids: 6 (lot 1)
bids: 6 (lot 1)
bids: 6 (lot 1)
bids: 6 (lot 1)
electronicBids: 6 (lot 1)
electronicBids: 6 (lot 1)
electronicBids: 6 (lot 1)
electronicBids: 6 (lot 1)
electronicBids: 6 (lot 1)
electronicBids: 6 (lot 1)
foreignBidsFromEU: 6 (lot 1)
foreignBidsFromEU: 6 (lot 1)
foreignBidsFromEU: 6 (lot 1)
foreignBidsFromEU: 6 (lot 1)
foreignBidsFromEU: 6 (lot 1)
foreignBidsFromEU: 6 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 1 (lot 1)
smeBids: 1 (lot 1)
smeBids: 1 (lot 1)
smeBids: 1 (lot 1)
smeBids: 1 (lot 1)
smeBids: 1 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-107961
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    7-8 Wellington Place, Leeds, UK, LS1 4AP
    katie.noonan@nhs.net

  • Baxter Healthcare Ltd
    supplier

    00461365
    Caxton Way, Thetford,, Norfolk,, UK, IP24 3SE

  • ITH Pharma
    supplier

    06569105
    Unit 4 Premier Park, Premier Park Road,, London, UK, NW10 7NZ

  • LloydsPharmacy Clinical Homecare
    supplier

    02764914
    Sapphire Court, Walsgrave Triangle,, Coventry,, UK, CV2 2TX

  • Qualasept Ltd t/a Bath ASU
    supplier

    05548345
    3 Corsham Science Park, Park Lane, Corsham,, Wilshire, UK, SN13 9FU

  • Quantum Pharmaceutical
    supplier

    05240304
    Quantum House, Hobson Industrial Estate, Burnopfield,, Co. Durham,, UK, NE16 6EA

  • Sciensus Pharma Services Limited
    supplier

    02759609
    107 Station Street,, Burton on Trent, Staffordshire,, UK, DE14 1SZ

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published